PAM Life Sciences
Advancing brain health throughout the female reproductive life cycle
© 2026 PAM Life Sciences Ltd. All rights reserved.
About
PAM Life Sciences is a biotechnology company advancing research into the biological mechanisms underlying perinatal mental health disorders. By translating cutting-edge scientific discoveries into practical solutions, we aim to improve understanding, enable earlier diagnosis, and support the development of more effective interventions for mothers and families worldwide.
Science
Our research focuses on uncovering the molecular pathways associated with perinatal mental health, with particular interest in the role of long non-coding RNAs (lncRNAs) potential therapeutic targets. We are committed to rigorous, translational science that bridges laboratory discovery with real-world clinical impact.
Team
Our multidisciplinary team brings together expertise in neuroscience, molecular biology, psychiatry, translational medicine, and innovation. United by a shared mission, we are working to accelerate scientific breakthroughs that have the potential to transform outcomes for women and their families.
Hamish Magoffin,
Co-Founder & CEO
Hamish Magoffin is Co-Founder and Chief Executive Officer of PAM Life Sciences, where he leads the company's strategic vision, partnerships and commercial development. He is committed to translating pioneering research into innovations that improve outcomes for women and families affected by perinatal mental health disorders.
Francis Szele,
Co-Founder & CSO
Professor Francis Szele is a leading neuroscientist and Oxford University DPAG faculty member, recruited to Oxford in 2007 after appointments and training at the University of Pennsylvania, Harvard Medical School, and Northwestern University Feinberg School of Medicine.His research focuses on brain development, neuroplasticity, neuroinflammation, and postpartum brain adaptation, and postnatal/adult neurogenesis. A recognised expert in brain stem cell niches, he was the first to show that brain injury can increase adult neurogenesis.At PAM Life Sciences, he applies deep academic and translational biotech expertise to develop new opportunities in neurological and maternal-brain health.
Suzanne Kianpour,
Co-Founder & Director of Strategic Partnerships
Suzanne leads strategic partnerships and external engagement, building relationships across academia, philanthropy, industry and the wider life sciences community. She supports the collaborations that enable PAM Life Sciences to accelerate research and maximise its impact.
Jemima Becker,
Research Scientist
Jemima Becker is a Research Scientist at PAM Life Sciences, where she investigates the molecular mechanisms underlying perinatal mental health disorders. Her work focuses on long non-coding RNAs and epigenetic regulation, contributing to the development of new approaches for understanding, diagnosing and treating postpartum depression.